Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06394973
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-06
First Post:
2024-04-29
Brief Title:
Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa Ophthalmic Solution in Patients with Open-angle Glaucoma or Ocular Hypertension
Sponsor:
Laboratoires Thea
Organization:
Laboratoires Thea
Study Overview
Official Title:
Efficacy and Safety Assessment of T4090 Ophthalmic Solution preservative-free Kinezodianone R HCl 02 or 03 Versus Rhopressa Ophthalmic Solution preserved Netarsudil 002 in Patients with Open-angle Glaucoma or Ocular Hypertension
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main purpose is to compare the ocular hypotensive efficacy and safety of two concentrations of T4090 Kinezodianone R HCl 02 and 03 ophthalmic solution with Rhopressa ophthalmic solution
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None